SyntheticMR appoints Johanna Norén as CFO and Head of Investor Relations

Report this content

SyntheticMR AB announced today that Johanna Norén is appointed CFO and Head of Investor Relations starting April 1, 2021. Johanna has worked as interim CFO at SyntheticMR and most recently came from Aebi Schmidt AB where she was the Financial Manager. She has over 20 years of experience in various finance and controller positions.

This disclosure contains information that SyntheticMR AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 10-03-2021 11:02 CET.

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 eller Johanna Norén, Interim CFO, SyntheticMR AB, +46 70 619 21 00

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked and FDA 510(k) pending. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit


Documents & Links